Equities

Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd

Actions
  • Price (INR)150.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.20k
  • 1 Year change+22.95%
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2024 04:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
ASSETS
Cash And Short Term Investments960.284.37
Total Receivables, Net11514960
Total Inventory965448
Prepaid expenses------
Other current assets, total595560
Total current assets366259173
Property, plant & equipment, net14188166
Goodwill, net------
Intangibles, net0.030.050.01
Long term investments403.921.29
Note receivable - long term--1.646.58
Other long term assets0.410.020.02
Total assets548353347
LIABILITIES
Accounts payable182197130
Accrued expenses------
Notes payable/short-term debt416478
Current portion long-term debt/capital leases------
Other current liabilities, total491419
Total current liabilities271276228
Total long term debt669.7093
Total debt10774171
Deferred income tax000.49
Minority interest----0.74
Other liabilities, total960.560.39
Total liabilities433286322
SHAREHOLDERS EQUITY
Common stock812323
Additional paid-in capital------
Retained earnings (accumulated deficit)35431.94
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1156625
Total liabilities & shareholders' equity548353347
Total common shares outstanding8.051111
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.